UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

Annals of oncology, 2013-07, Vol.24 (7), p.1813-1821

2013

Volltextzugriff (PDF)

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer

Annals of oncology, 2012-10, Vol.23 (10), p.2714-2719

2012

Volltextzugriff (PDF)

Carbohydrate Vaccines in Cancer: Immunogenicity of a Fully Synthetic Globo H Hexasaccharide Conjugate in Man

Proceedings of the National Academy of Sciences - PNAS, 1999-05, Vol.96 (10), p.5710-5715

1999

Volltextzugriff (PDF)

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers

Clinical cancer research, 1998-02, Vol.4 (2), p.295-302

1998

Volltextzugriff (PDF)

Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration

Annals of oncology, 2003-10, Vol.14 (10), p.1518-1524

2003

Volltextzugriff (PDF)

Polyclonal Antibodies from Patients Immunized with a Globo H-Keyhole Limpet Hemocyanin Vaccine: Isolation, Quantification, and Characterization of Immune Responses by Using Totally Synthetic Immobilized Tumor Antigens

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (6), p.2719-2724

2000

Volltextzugriff (PDF)

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine : clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

Cancer Immunology, Immunotherapy, 2005-07, Vol.54 (7), p.694-702

2005

Volltextzugriff (PDF)

Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man--clinical trials at Memorial Sloan-Kettering Cancer Center

Seminars in oncology, 1999-08, Vol.26 (4), p.448-454

1999

Volltextzugriff (PDF)

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

Vaccine, 2005-05, Vol.23 (24), p.3114-3122

2005

Volltextzugriff (PDF)

Detectable tumor cells in the blood and bone marrow: smoke or fire?

Cancer, 1998-08, Vol.83 (3), p.394-398

1998

Volltextzugriff (PDF)

Vaccines as treatment strategies for relapsed prostate cancer: approaches for induction of immunity

Hematology/oncology clinics of North America, 2001-06, Vol.15 (3), p.477-496

Slovin, S F

2001

Volltextzugriff (PDF)

Targeted therapy for prostate cancer : The Memorial Sloan-Kettering Cancer Center approach

Seminars in oncology, 1996-12, Vol.23 (6), p.41-48

1996

Volltextzugriff (PDF)

DNA vaccines: an active immunization strategy for prostate cancer

Seminars in oncology, 2003-10, Vol.30 (5), p.659-666

2003

Volltextzugriff (PDF)

Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity

The Journal of immunology (1950), 1986-11, Vol.137 (9), p.3042-3048

1986

Volltextzugriff (PDF)

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer

Clinical cancer research, 1998-03, Vol.4 (3), p.643-651

1998

Volltextzugriff (PDF)

A phase II trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

Cancer, 2018-11, Vol.125 (4), p.524-532

2018

Volltextzugriff (PDF)

HER-2 profiling and targeting in prostate carcinoma: A phase II trial of trastuzumab alone and with paclitaxel

Cancer, 2002-02, Vol.94 (4), p.980-986

2002

Volltextzugriff (PDF)

Antibodies to Epstein-Barr Virus-Determined Antigens in Normal Subjects and in Patients with Seropositive Rheumatoid Arthritis

Proceedings of the National Academy of Sciences - PNAS, 1979-11, Vol.76 (11), p.5825-5828

1979

Volltextzugriff (PDF)

Harnessing T‐lymphocytes for human cancer immunotherapy

Cancer, 1985-09, Vol.56 (6), p.1366-1373

1985

Volltextzugriff (PDF)

Carbohydrate vaccines as immunotherapy for cancer

Immunology and cell biology, 2005-08, Vol.83 (4), p.418-428

2005

Volltextzugriff (PDF)

Chemotherapy for androgen- independent prostate cancer: myth or reality

Current oncology reports, 2000-09, Vol.2 (5), p.394-401

2000

Volltextzugriff (PDF)

Fully Synthetic Carbohydrate-Based Vaccines in Biochemically Relapsed Prostate Cancer: Clinical Trial Results With α-N-Acetylgalactosamine-O-Serine/Threonine Conjugate Vaccine

Journal of clinical oncology, 2003-12, Vol.21 (23), p.4292-4298

2003

Volltextzugriff (PDF)

Time to Detectable Metastatic Disease in Patients with Rising Prostate-Specific Antigen Values following Surgery or Radiation Therapy

Clinical cancer research, 2005-12, Vol.11 (24), p.8669-8673

2005

Volltextzugriff (PDF)

Membrane Antigen on Epstein-Barr Virus-Infected Human B Cells Recognized by a Monoclonal Antibody

Proceedings of the National Academy of Sciences - PNAS, 1982-04, Vol.79 (8), p.2649-2653

1982

Volltextzugriff (PDF)

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Journal of clinical oncology, 2004-02, Vol.22 (3), p.537-556

2004

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Englisch
(291)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer

Carbohydrate Vaccines in Cancer: Immunogenicity of a Fully Synthetic Globo H Hexasaccharide Conjugate in Man

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers

Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration

Polyclonal Antibodies from Patients Immunized with a Globo H-Keyhole Limpet Hemocyanin Vaccine: Isolation, Quantification, and Characterization of Immune Responses by Using Totally Synthetic Immobilized Tumor Antigens

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine : clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man--clinical trials at Memorial Sloan-Kettering Cancer Center

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

Detectable tumor cells in the blood and bone marrow: smoke or fire?

Vaccines as treatment strategies for relapsed prostate cancer: approaches for induction of immunity

Targeted therapy for prostate cancer : The Memorial Sloan-Kettering Cancer Center approach

DNA vaccines: an active immunization strategy for prostate cancer

Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer

A phase II trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

HER-2 profiling and targeting in prostate carcinoma: A phase II trial of trastuzumab alone and with paclitaxel

Antibodies to Epstein-Barr Virus-Determined Antigens in Normal Subjects and in Patients with Seropositive Rheumatoid Arthritis

Harnessing T‐lymphocytes for human cancer immunotherapy

Carbohydrate vaccines as immunotherapy for cancer

Chemotherapy for androgen- independent prostate cancer: myth or reality

Fully Synthetic Carbohydrate-Based Vaccines in Biochemically Relapsed Prostate Cancer: Clinical Trial Results With α-N-Acetylgalactosamine-O-Serine/Threonine Conjugate Vaccine

Time to Detectable Metastatic Disease in Patients with Rising Prostate-Specific Antigen Values following Surgery or Radiation Therapy

Membrane Antigen on Epstein-Barr Virus-Infected Human B Cells Recognized by a Monoclonal Antibody

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Suchergebnisse filtern